KURA
Kura OncologyDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
KURA vs peer average
37/100
KURA vs. peer average (D vs. C)
Grade spread
A 2 · B 1 · C 3 · D 3 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
DSGN is the first available peer comparator.
Same-sector, similarly sized biotechnology peer; provides broad event-driven biotech context but no direct indication or asset overlap is established in the packet.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
KURA
Kura Oncology
DSGN
Design Therapeutics
Grade
D
A
Momentum
23
17
Value
41
41
Sentiment
65
92
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs DSGN
KURA / DSGN
Grade Position
Below peers
KURA vs. peer average (D vs. C)
37/100
Momentum
23
KURAValue
41
KURASentiment
65
DSGNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs KURA
DSGN is the first peer returned for this comparison set.